Markers for different glial cell responses in multiple sclerosis: Clinical and pathological correlations

Brain

Volumn 125, Issue 7, 2002, Pages 1462-1473

  Petzold, A ^a   Eikelenboom, M J ^b   Gveric, D ^a   Keir, G ^a   Chapman, M ^a   Lazeron, R H C ^b   Cuzner, M L ^b   Polman, C H ^b   Uitdehaag, B M J ^a   Thompson, E J ^a   Giovannoni, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain tissue; CSF; Ferritin; GFAP; S100B

Indexed keywords

FERRITIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RATING SCALE; SCORING SYSTEM;

EID: 0036314155     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf165     Document Type: Article

References (61)

1. S100B expression in and effects on microglia
2. High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus
3. Quantification of impairment in MS: Discussion of the scales in use
4. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report
5. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction
6. The microglial cell. A historical review
7. Axonal loss in normal-appearing white matter in a patient with acute MS
8. Glial fibrillary acidic protein in the cerebrospinal fluid: A possible indicator of prognosis in full-term asphyxiated newborn infants
9. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis
10. Histologie de la sclérose en plaques
11. Relationship of iron to oligodendrocytes and myelination
12. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions increased yield of active demyelinating and (p) reactive lesions
13. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
14. Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis
15. GFAP astrogliosis
16. A study of proteins in old multiple sclerosis plaques
17. Magnetization transfer changes in normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis
18. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
19. A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid
20. Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia
21. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
22. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin
23. Plasminogen activators in multiple sclerosis lesions: Implications for the inflammatory response and axonal damage
24. S-100b stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants
25. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography
26. Purification and characterization of adipose tissue S-100b protein
27. Distribution of transferrin and ferritin binding in normal and multiple sclerotic brains
28. Extra cranial sources of S100B
29. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis
30. Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis
31. MS functional composite: Relation to disease phenotype and disability strata
32. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: An annotated update
33. Cerebrospinal fluid ferritin in brain necrosis: Evidence for local synthesis
34. Reaction of the neuronal cell body to axonal damage
35. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
36. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders
37. Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients
38. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients
39. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques
40. Defining the clinical course of multiple sclerosis: Results of an international survey
41. Myelin basic protein and S-100 antigen in cerebrospinal fluid of patients with multiple sclerosis in the acute phase
42. La patologia gliale nella sclerosi multipla evidenziata mediante l'analisi liquorale
43. The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system
44. S-100 protein in the testis. An immunochemical and immunohistochemical study
45. Measurement of glial fibrillary acidic protein in human blood: Analytical method and preliminary clinical results
46. Distribution of glial fibrillary acidic protein in gliosed human white matter
47. Monoclonal antibody 14E recognizes an antigen common to human oligodendrocytes, Schwann cells, Bergmann glia, and a subpopulation of reactive glia
48. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology
49. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
50. A sensitive ELISA for glial fibrillary acidic protein: Application in CSF of children
51. Glial fibrillary acidic protein in CSF of multiple sclerosis patients: Relation to neurological deficit
52. Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy
53. Functional plasticity of microglia: A review
54. S-100 protein in clonal astroglioma cells is released by adrenocorticotropic hormone and corticotropin-like intermediate-lobe peptide
55. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues
56. Protein markers of brain damage
57. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis
58. Axonal transection in the lesions of multiple sclerosis
59. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage